280P Intracranial activity of trastuzumab-deruxtecan (T-DXd) in HER2-positive breast cancer patients with active brain metastases: Results from the first stage of the phase II TUXEDO-1 trial
Under an Elsevier user license
open archive
Cited by (0)
Copyright © 2021 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved.